These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 20574808)
41. Genomic Pathology and Biomarkers in Breast Cancer. Zhang Z; Tang P Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921 [TBL] [Abstract][Full Text] [Related]
42. A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival. Bacac M; Provero P; Mayran N; Stehle JC; Fusco C; Stamenkovic I PLoS One; 2006 Dec; 1(1):e32. PubMed ID: 17183660 [TBL] [Abstract][Full Text] [Related]
43. Expression signature developed from a complex series of mouse models accurately predicts human breast cancer survival. He M; Mangiameli DP; Kachala S; Hunter K; Gillespie J; Bian X; Shen HC; Libutti SK Clin Cancer Res; 2010 Jan; 16(1):249-59. PubMed ID: 20028755 [TBL] [Abstract][Full Text] [Related]
44. Mouse models of breast cancer. Sakamoto K; Schmidt JW; Wagner KU Methods Mol Biol; 2015; 1267():47-71. PubMed ID: 25636464 [TBL] [Abstract][Full Text] [Related]
45. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets. Stanton SE; Gad E; Corulli LR; Lu H; Disis ML Vaccine; 2019 Jun; 37(27):3552-3561. PubMed ID: 31126858 [TBL] [Abstract][Full Text] [Related]
46. Genetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer. Annunziato S; Barazas M; Rottenberg S; Jonkers J Cold Spring Harb Symp Quant Biol; 2016; 81():141-150. PubMed ID: 27815543 [TBL] [Abstract][Full Text] [Related]
47. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Radvanyi L; Singh-Sandhu D; Gallichan S; Lovitt C; Pedyczak A; Mallo G; Gish K; Kwok K; Hanna W; Zubovits J; Armes J; Venter D; Hakimi J; Shortreed J; Donovan M; Parrington M; Dunn P; Oomen R; Tartaglia J; Berinstein NL Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11005-10. PubMed ID: 16043716 [TBL] [Abstract][Full Text] [Related]
48. Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models. Bennett CN; Green JE Breast Cancer Res; 2008; 10(5):213. PubMed ID: 18828875 [TBL] [Abstract][Full Text] [Related]
49. [Proteomics of breast cancer: From differential to functional analysis]. Hondermarck H J Soc Biol; 2006; 200(2):199-202. PubMed ID: 17151556 [TBL] [Abstract][Full Text] [Related]
50. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462 [TBL] [Abstract][Full Text] [Related]
51. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746 [TBL] [Abstract][Full Text] [Related]
52. Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations. Zhang X; Podsypanina K; Huang S; Mohsin SK; Chamness GC; Hatsell S; Cowin P; Schiff R; Li Y Oncogene; 2005 Jun; 24(26):4220-31. PubMed ID: 15824740 [TBL] [Abstract][Full Text] [Related]
53. The promise of microarrays in the management and treatment of breast cancer. Chang JC; Hilsenbeck SG; Fuqua SA Breast Cancer Res; 2005; 7(3):100-4. PubMed ID: 15987438 [TBL] [Abstract][Full Text] [Related]
54. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis. Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975 [TBL] [Abstract][Full Text] [Related]
56. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318 [TBL] [Abstract][Full Text] [Related]
57. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Turpin J; Ling C; Crosby EJ; Hartman ZC; Simond AM; Chodosh LA; Rennhack JP; Andrechek ER; Ozcelik J; Hallett M; Mills GB; Cardiff RD; Gray JW; Griffith OL; Muller WJ Oncogene; 2016 Nov; 35(47):6053-6064. PubMed ID: 27157621 [TBL] [Abstract][Full Text] [Related]
58. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246 [TBL] [Abstract][Full Text] [Related]
59. Molecular characterization of breast cancer cell lines through multiple omic approaches. Smith SE; Mellor P; Ward AK; Kendall S; McDonald M; Vizeacoumar FS; Vizeacoumar FJ; Napper S; Anderson DH Breast Cancer Res; 2017 Jun; 19(1):65. PubMed ID: 28583138 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA expression profiling of male breast cancer. Fassan M; Baffa R; Palazzo JP; Lloyd J; Crosariol M; Liu CG; Volinia S; Alder H; Rugge M; Croce CM; Rosenberg A Breast Cancer Res; 2009; 11(4):R58. PubMed ID: 19664288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]